Table 2.
Plasma WISP-1 Levels in Patients With Type 2 Diabetes: Bivariate Correlation Analyses
| Parameter | Correlation Coefficienta | P Value |
|---|---|---|
| Sex | −0.15 | 0.23b |
| Age | −0.15 | 0.22 |
| T2D duration | −0.17 | 0.17 |
| BMI | 0.04 | 0.77 |
| Waist circumference | −0.006 | 0.95 |
| SBP | −0.05 | 0.69 |
| DBP | −0.24 | 0.06 |
| FBG | 0.01 | 0.92 |
| HOMA-IR | −0.009 | 0.94 |
| HOMA-β% | −0.11 | 0.41 |
| HbA1c | −0.09 | 0.49 |
| IL-8 | 0.71 | <0.0001 |
| Adiponectin | −0.25 | 0.04 |
| VAT area | 0.56 | 0.005 |
| SAT area | −0.37 | 0.01 |
| VAT/SAT ratio | 0.26 | 0.03 |
| NAFLD (yes/no) | 0.10 | 0.39b |
Abbreviations: DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HOMAβ%, homeostasis model assessment of insulin secretion; HOMA-IR, homeostasis model assessment of insulin resistance; SBP, systolic blood pressure; T2D, type 2 diabetes.
a
Pearson correlation coefficients are shown.
b
Spearman correlation coefficient, with WISP-1 as a continuous variable.